ScreenerHero

XWEL XWELL, Inc.

NAS · US · Healthcare · Diagnostics & Research · xwell.com
0.9020USD+12.61%Mkt Cap: 7.75M $P/E: —

XWELL, Inc. engages in the provision of health and wellness services to travelers in the United States and internationally. It operates in three segments: XpresSpa, XpresTest, and Naples Wax Center. The XpresSpa segment …

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$244.79BUSDP/E 36.7
DHR
Danaher Corporation
$153.60BUSDP/E 38.9
NTRA
Natera, Inc.
$57.02BUSD
LONN
Lonza Group AG
$46.01BUSDP/E 38.3
A
Agilent Technologies, Inc.
$47.67BUSDP/E 33.4
WAT
Waters Corporation
$42.81BUSDP/E 110.4
IQV
IQVIA Holdings Inc.
$42.48BUSDP/E 32.1
ILMN
Illumina, Inc.
$40.43BUSDP/E 50.0
IDXX
IDEXX Laboratories, Inc.
$39.97BUSDP/E 35.6
MTD
Mettler-Toledo International Inc.
$30.73BUSDP/E 34.6
LH
Labcorp Holdings Inc.
$25.30BUSDP/E 25.8
DGX
Quest Diagnostics Incorporated
$25.06BUSDP/E 24.1
GH
Guardant Health, Inc.
$22.59BUSD
RVTY
Revvity, Inc.
$17.14BUSDP/E 73.5
MEDP
Medpace Holdings, Inc.
$16.87BUSDP/E 35.5
ERF
Eurofins Scientific SE
$14.23BUSDP/E 26.6
CRL
Charles River Laboratories International, Inc.
$14.34BUSD
ICLR
ICON Public Limited Company
$12.66BUSDP/E 172.7
BIM
bioMérieux S.A.
$10.35BUSDP/E 20.7
QGEN
Qiagen N.V.
$9.25BUSDP/E 22.7

Key Statistics

Company
Market Cap7.75M USD
Enterprise Value12.50M USD
Revenue (TTM)28.28M USD
Gross Profit7.51M USD
Net Income (TTM)-16.99M USD
Revenue/Share4.12 USD
Last Price0.9020 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees175
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.30
PEG—
EV/EBITDA-1.26
EV/Revenue0.44
P/S0.24
P/B-3.66
EPS (TTM)-5.24
EPS (Forward)-2.63
52W Range
0.260033% of range2.200
52W High2.200 USD
52W Low0.2600 USD
Profitability
Gross Margin25.70%
Oper. Margin-26.10%
EBITDA Margin-35.15%
Profit Margin-58.17%
ROE77.10%
ROA-151.48%
Growth
Revenue Growth-7.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-8.71M USD
CapEx (TTM)2.96M USD
FCF Margin-28.82%
FCF Yield-105.22%
Net Debt-4.49M USD
Net Debt/EBITDA0.45
Balance Sheet
Debt/Equity-0.57
Current Ratio2.27
Quick Ratio2.04
Book Value/Sh-0.22 USD
Cash/Share1.37 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJun 11, 2020
Splits
Last Split1:20
Split DateSep 28, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.8.59M
Float5.81M
Insiders27.11%
Institutions16.83%
Short Interest
Short Ratio4.0d
Short % Float2.11%
Short % Out.1.82%
Shares Short156.57K
Short (prev mo.)179.41K
Technical
SMA 500.9534 (-5.4%)
SMA 2000.9853 (-8.5%)
Beta0.94
S&P 52W Chg16.45%
Avg Vol (30d)37.21K
Avg Vol (10d)33.71K
Technical Indicators
RSI (14)49.3
MACD-0.0390
MACD Signal-0.0391
MACD Hist.+0.0001
BB Upper0.9936 USD
BB Middle0.8934 USD
BB Lower0.7932 USD
BB Width22.44%
ATR (14)0.0513 USD
Vol Ratio (20d)2.04x